District Court The Hague, The Netherlands, 12 May 2017, Case No. ECLI:NL:RBDHA:2017:5035

Injunction against biosimilar of Retuximab denied. Reasonable chance that the patent will be invalidated due to added matter.

A copy of the judgment can be read here.